iMediSync Inc. (주식회사 아이메디신)

iMediSync is a South Korean digital mental health platform company specializing in AI-driven biomarker detection and analysis for brain and cardiac health. The company designs and manufactures proprietary dry-electrode wearable headsets for non-invasive measurement of brainwave (EEG) and heart rate variability (HRV) signals without gel or conductive pastes. iMediSync operates three primary product lines: iSyncWave (wireless dry-electrode EEG measurement headset with integrated care capabilities), iSyncBrain (cloud-based AI brainwave analytics software with quantitative EEG analysis and cognitive impairment screening), and iSyncHeart (cloud-based HRV analytics for stress, anxiety, and depression monitoring). The company has obtained regulatory clearance in South Korea (식약처 approval for both device and software), US FDA Class II clearance for iSyncWave, and FDA software device authorization for iSyncBrain. iMediSync maintains proprietary age- and gender-stratified EEG reference databases and employs machine learning models for automated noise removal, brain mapping, and clinical decision support. Applications span clinical neurology, psychiatry, occupational health screening, and research collaborations. The platform supports early detection of mild cognitive impairment and stress-related autonomic nervous system imbalance.